Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

European CPMP emits positive opinion on Zeffix for chronic HBV

April 27, 1999

U.S. study now under way using artificial liver device incorporating human cells

April 27, 1999

Thalidomide receives orphan drug status for Crohn's disease

April 21, 1999

SciClone and Sigma-Tau sign Zadaxin partnership

April 19, 1999

COX-2 inhibitors can potentially be used safely in patients with decompensated cirrhosis

April 19, 1999

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

April 16, 1999

Data on adefovir dipivoxil against HBV presented at EASL conference

April 16, 1999

Neurokinin antagonists for IBS synthesized and evaluated at Solvay

April 15, 1999

FDA requires further info about Hepagene vaccine

April 15, 1999

Colazide receives pricing approval in Sweden

April 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...